Metairie, LA, United States of America

Abba J Kastin


Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 314(Granted Patents)

Location History:

  • New Orleans, LA (US) (1978)
  • Metairie, LA (US) (1978 - 2001)


Years Active: 1978-2001

where 'Filed Patents' based on already Granted Patents

31 patents (USPTO):

Title: Abba J. Kastin: Innovator in Mu-Opiate Receptor Peptides

Introduction

Abba J. Kastin, based in Metairie, LA, is a renowned inventor with a remarkable portfolio of 31 patents. His work primarily focuses on the development of advanced peptide therapeutics targeting the mu-opiate receptor, essential for addressing pain management and drug dependence.

Latest Patents

Kastin's latest innovations center around mu-opiate receptor peptides. These inventions introduce specific peptides and their linear and cyclic analogs that exhibit greater binding affinity, selectivity, and potency for the mu-opiate receptor than currently existing peptides. Additionally, his inventions encompass pharmaceutical preparations that contain these peptides or their salts, offering effective methods for analgesia, alleviating gastrointestinal issues such as diarrhea, and providing therapies for drug dependence.

Career Highlights

Throughout his career, Kastin has made significant contributions to the field of medicinal chemistry and pharmacology. His inventive efforts have led to advancements that are critical in the development of new treatments for pain and addiction, enhancing the landscape of pharmaceutical science.

Collaborations

Kastin has collaborated with distinguished professionals, including David H. Coy and James E. Zadina. These collaborations have enabled the synergistic advancement of their respective research, focusing on innovative approaches to tackling complex medical challenges. He has also been associated with the Administrators of the Tulane Educational Fund, further showcasing his commitment to research and education.

Conclusion

Abba J. Kastin's extensive experience and inventive contributions to the field of mu-opiate receptor peptides emphasize his significant role as an innovator. His patents not only represent scientific achievement but also aim to improve therapeutic outcomes in pain management and treatment for drug dependence, solidifying his legacy as a leading inventor in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…